Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Daizheng Lian"'
Publikováno v:
Pharmaceutics, Vol 16, Iss 9, p 1208 (2024)
Glucose, a primary energy source derived from animals’ feed ration, is crucial for their growth, production performance, and health. However, challenges such as metabolic stress, oxidative stress, inflammation, and gut microbiota disruption during
Externí odkaz:
https://doaj.org/article/63676c3111b8421fb0ed8d91839bd523
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Dacarbazine (DTIC) dominates chemotherapy for malignant melanoma (MM). However, the hydrophobicity, photosensitivity, instability, and toxicity to normal cells of DTIC limit its efficacy in treating MM. In the present study, we constructed star-shape
Externí odkaz:
https://doaj.org/article/1258c51ccc974367974c675d86023137
Autor:
Hualin Ma, Jingwen Peng, Jianing Zhang, Li Pan, Jiayi Ouyang, Zimu Li, Baochun Guo, Zhen Wang, Ying Xu, Daizheng Lian, Xiaowei Zeng
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 15 (2022)
Polydopamine (PDA) is a natural melanin derived from marine mussels that has good biocompatibility, biodegradability, and photothermal conversion ability. As a new coating material, it offers a novel way to modify the surface of various substances. T
Externí odkaz:
https://doaj.org/article/dce5f7479aca4114b55618654e86b97c
Autor:
Qingyun Liu, Li Yang, Liangliang Wang, Zimu Li, Yongkang Yu, Yi Zheng, Daizheng Lian, Xianming Li, Hongzhong Chen, Lin Mei, Xiaowei Zeng, Nansha Gao
Publikováno v:
International Journal of Biological Macromolecules. :125064
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b74c67ba9263fbd470fde40b1a8312f
https://doi.org/10.1016/j.ijbiomac.2023.125064
https://doi.org/10.1016/j.ijbiomac.2023.125064
Publikováno v:
International Journal of Nanomedicine. 15:1469-1480
Purpose In spite of its enhanced efficacy and reduced side effects in clinical hepatocellular carcinoma (HCC) therapy, the therapeutic efficacy of antitumor angiogenesis inhibitor sorafenib (SFB) is still restricted due to short in vivo half-life and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::015d42a6957dbf7d3c09f05cd3eb4ba7
https://doi.org/10.2147/ijn.s237335
https://doi.org/10.2147/ijn.s237335
Autor:
Min Zhang, Zihuang Li, Daizheng Lian, Heping Wang, Chaoyu Liang, Xiaowei Zeng, Wei Cheng, Zhenhua Xie, Gan Liu, Junpeng Nie, Laiqiang Huang
Publikováno v:
Journal of Colloid and Interface Science. 525:1-10
Oxaliplatin is a promising antitumor drug, but its effectiveness is limited by its side effects in vivo. In this study, we introduced an Oxaliplatin prodrug (Oxa(IV)) self-controlled release strategy, in which Oxa(IV) is encapsulated by TPGS function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da02a27de46127d5df6e2945a9c6eff
https://doi.org/10.1016/j.jcis.2018.04.058
https://doi.org/10.1016/j.jcis.2018.04.058
Autor:
Daizheng Lian, Yuhan Chen, Xiaowei Zeng, Zihuang Li, Gang Xu, Zhuangling Li, Xianming Li, Lin Mei, Yayan Zhou
Publikováno v:
RSC Advances. 6:37740-37749
Hypoxia inducible factor-1α (HIF-1α) related signaling pathways mediating chemoresistance has been found in various kinds of cancer, including nasopharyngeal carcinoma (NPC). In this research, a chitosan modified D-α-tocopheryl polyethylene glycol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5619bd2f21f794c38cf4534c7fe3458f
https://doi.org/10.1039/c6ra03440c
https://doi.org/10.1039/c6ra03440c
Autor:
Lin, Wei-Chih1,2 (AUTHOR) weichih.lin@kemin.com, Hoe, Boon-Chin1,2 (AUTHOR) boonchin.hoe@kemin.com, Li, Xianming3 (AUTHOR) lixianming1828@hotmail.com, Lian, Daizheng3 (AUTHOR) ldz3446@126.com, Zeng, Xiaowei1 (AUTHOR) ldz3446@126.com
Publikováno v:
Pharmaceutics. Sep2024, Vol. 16 Issue 9, p1208. 31p.
Autor:
Ma, Hualin1 (AUTHOR), Peng, Jingwen2 (AUTHOR), Zhang, Jianing2 (AUTHOR), Pan, Li2 (AUTHOR), Ouyang, Jiayi2 (AUTHOR), Li, Zimu2 (AUTHOR), Guo, Baochun1 (AUTHOR), Wang, Zhen1 (AUTHOR), Xu, Ying3 (AUTHOR), Lian, Daizheng4 (AUTHOR) ldz3446@126.com, Zeng, Xiaowei2 (AUTHOR) ldz3446@126.com
Publikováno v:
Pharmaceutics. Jan2023, Vol. 15 Issue 1, p15. 20p.
Publikováno v:
Drug Week; 10/4/2024, p179-179, 1p